Deal News

  • 28 September 2018

    Deals this week: Immutep, Enesi Pharma, LineaRx

    Australian biotechnology company Immutep has entered a clinical trial collaboration agreement with Merck and Pfizer to develop a new cancer immunotherapy combination therapy.